Literature DB >> 17449524

Childhood immunisation: what is the future?

Andrew J Pollard1.   

Abstract

Improved immunisation programmes and the development of new vaccines provide unprecedented opportunities to improve and sustain the health of our children. There are major challenges ahead in communicating the benefits of immunisation to all populations and in delivering vaccines to those in greatest need. In this review on immunisation, I have asked international opinion leaders to comment on the present and the future of immunisation to provide signposts for the narrative.

Entities:  

Mesh：

Year:  2007        PMID： 17449524      PMCID： PMC2083746          DOI： 10.1136/adc.2006.095760

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  27 in total

1.  Child vaccination policies in Europe: a report from the Summits of Independent European Vaccination Experts.

Authors:  Heinz J Schmitt; Robert Booy; Catherine Weil-Olivier; Pierre Van Damme; Robert Cohen; Heikki Peltola
Journal:  Lancet Infect Dis       Date:  2003-02       Impact factor: 25.071

2.  Immunogenicity and safety of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine as a pre-school booster in UK children.

Authors:  C L Collins; P Salt; N McCarthy; T Chantler; L Lane; F Hemme; L Diggle; J Buttery; N R E Kitchin; E R Moxon; A J Pollard
Journal:  Vaccine       Date:  2004-10-22       Impact factor: 3.641

Review 3.  The paediatric burden of rotavirus disease in Europe.

Authors: 
Journal:  Epidemiol Infect       Date:  2006-04-04       Impact factor: 2.451

4.  The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children.

Authors:  K M Neuzil; B G Mellen; P F Wright; E F Mitchel; M R Griffin
Journal:  N Engl J Med       Date:  2000-01-27       Impact factor: 91.245

Review 5.  Meningococcal polysaccharide-protein conjugate vaccines.

Authors:  Matthew D Snape; Andrew J Pollard
Journal:  Lancet Infect Dis       Date:  2005-01       Impact factor: 25.071

6.  Effectiveness over time of varicella vaccine.

Authors:  Marietta Vázquez; Philip S LaRussa; Anne A Gershon; Linda M Niccolai; Catherine E Muehlenbein; Sharon P Steinberg; Eugene D Shapiro
Journal:  JAMA       Date:  2004-02-18       Impact factor: 56.272

7.  Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction.

Authors:  Caroline L Trotter; Nick J Andrews; Edward B Kaczmarski; Elizabeth Miller; Mary E Ramsay
Journal:  Lancet       Date:  2004 Jul 24-30       Impact factor: 79.321

8.  Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method.

Authors:  Mary E Ramsay; Jodie McVernon; Nick J Andrews; Paul T Heath; Mary P Slack
Journal:  J Infect Dis       Date:  2003-07-31       Impact factor: 5.226

9.  A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection.

Authors:  Keith P Klugman; Shabir A Madhi; Robin E Huebner; Robert Kohberger; Nontombi Mbelle; Nathaniel Pierce
Journal:  N Engl J Med       Date:  2003-10-02       Impact factor: 91.245

10.  Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial.

Authors:  Diane M Harper; Eduardo L Franco; Cosette Wheeler; Daron G Ferris; David Jenkins; Anne Schuind; Toufik Zahaf; Bruce Innis; Paulo Naud; Newton S De Carvalho; Cecilia M Roteli-Martins; Julio Teixeira; Mark M Blatter; Abner P Korn; Wim Quint; Gary Dubin
Journal:  Lancet       Date:  2004 Nov 13-19       Impact factor: 79.321
View more
  6 in total

Review 1.  Protection against severe infectious disease in the past.

Authors:  Alexander Mercer
Journal:  Pathog Glob Health       Date:  2021-02-11       Impact factor: 2.894

2.  Effective Respiratory CD8 T-Cell Immunity to Influenza Virus Induced by Intranasal Carbomer-Lecithin-Adjuvanted Non-replicating Vaccines.

Authors:  David J Gasper; Brandon Neldner; Erin H Plisch; Hani Rustom; Emily Carrow; Hirotaka Imai; Yoshihiro Kawaoka; M Suresh
Journal:  PLoS Pathog       Date:  2016-12-20       Impact factor: 6.823

3.  Multi-Antibiotic Resistance and Factors Affecting Carriage of Extended Spectrum β-Lactamase-Producing Enterobacteriaceae in Pediatric Population of Enugu Metropolis, Nigeria.

Authors:  Angus N Oli; Vitalis I Ogbuagu; Chika P Ejikeugwu; Ifeanyichukwu R Iroha; Malachy C Ugwu; Chijioke M Ofomata; Kenneth N Okeke; George O Emechebe; Jude C Okoro; Chukwudi O Okani; Stanley K Onah
Journal:  Med Sci (Basel)       Date:  2019-11-17

4.  Teenagers' understandings of and attitudes towards vaccines and vaccine-preventable diseases: a qualitative study.

Authors:  S Hilton; C Patterson; E Smith; H Bedford; K Hunt
Journal:  Vaccine       Date:  2013-04-18       Impact factor: 3.641

5.  Analysis of health outcomes in vaccinated and unvaccinated children: Developmental delays, asthma, ear infections and gastrointestinal disorders.

Authors:  Brian S Hooker; Neil Z Miller
Journal:  SAGE Open Med       Date:  2020-05-27

Review 6.  Multiple Vaccinations and the Enigma of Vaccine Injury.

Authors:  Anthony R Mawson; Ashley M Croft
Journal:  Vaccines (Basel)       Date:  2020-11-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.